Derry Ridgway, M.D.
Senior Medical Director
product development

Derry Ridgway is a Senior Medical Director at Constella. He provides medical oversight for projects, strategic consulting on overall drug development issues, and writing services on regulatory and non-regulatory projects. Ridgway joined Constella through its acquisition of Lineberry Research Associates (LRA) in 2006.

Ridgway has more than 25 years of experience in academic biomedical research. Prior to joining LRA, Ridgway served as Medical Director and Staff Physician at Legacy Urgent Care in St. Helens, Oregon, Associate Professor of Pediatrics at Oregon Health Sciences University, and as a naval medical officer from 1974 to 1976. Ridgway's primary areas of research and publication include the toxic immunologic effects of antineoplastic therapy, immune modulation, and pediatric epidemiology.

Ridgway is board certified in pediatrics and sub-board certified in pediatric hematology and oncology. He earned a B.A. in mathematics and psychology from Occidental College, an M.A.T. from Harvard University, an M.A. in biostatistics and a J.D. from the University of California, Berkeley, and his M.D. from the University of California, San Diego.